Ober Scharrer Gruppe acquired Eyescan
Ober Scharrer Gruppe (“Ober Scharrer”), a German eye care provider, acquired the leading Dutch eye care provider Eyescan. The acquisition of Eyescan is the first cross-border transaction of Ober Scharrer. PhiDelphi advised Ober Scharrer and Nordic Capital in the competitive process.
PhiDelphi has extensive transaction experience in the healthcare sector, including the sale of Excent to Nordic Capital, the sale of Mauritsklinieken to Holland Capital, the sale of Winnock, a subsidiary of Achmea, to Zorg van de Zaak and the sale of NedSpine to NL Healthcare.
Eyescan (www.eyescan.nl), established in 1999, is a leading Dutch eyecare clinic chain. The company provides eyecare surgery services, treats eye diseases and provides cosmetic eye services. Eyescan operates seven clinics in the Netherlands including several joint ventures with hospitals.
Ober Scharrer (www.osg.de), founded in 1982, providing ophthalmic treatments and medical care across Germany. The company employees about 1.600 persons, operates over 25 locations and threats over 800.000 patients per year. In March 2018, Nordic Capital acquired a majority of the shares in Ober Scharrer.
Nordic Capital (www.nordiccapital.com) is a leading private equity investor in the Nordic region. The company aims to create stronger, sustainable businesses through operational improvement and transformative growth. Core sectors of Nordic Capital are Healthcare, Technology & Payments, Financial Services, Industrial Goods & Services and Consumer & Retail, and key regions are the Nordics and Northern Europe with a global focus for Healthcare. Since inception in 1989, Nordic Capital has invested EUR 12 billion in close to 100 investments.